Medexus to Present at the Sidoti & Company Virtual Microcap Conference on May 19th
May 12, 2021 08:30 ET
|
Medexus Pharmaceuticals Inc
TORONTO, CHICAGO and MONTREAL, May 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it will be...
Medexus Announces Conference Participation for April 2021
April 12, 2021 08:30 ET
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO and MONTREAL, April 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731), today announced that Ken...
Medexus Reports All Medexus Non-Executive Directors Choose RSUs in Lieu of Cash Fees
March 31, 2021 17:05 ET
|
Medexus Pharmaceuticals Inc
TORONTO, CHICAGO and MONTREAL, March 31, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) is pleased to report that the...
Medexus to Participate in the 33rd Annual ROTH Conference on March 15-17, 2021
March 08, 2021 08:30 ET
|
Medexus Pharmaceuticals Inc
TORONTO, CHICAGO and MONTREAL, March 08, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that Ken...
Medexus Achieves Record Revenue of $31.5 Million for the Third Quarter Fiscal 2021
March 01, 2021 17:00 ET
|
Medexus Pharmaceuticals Inc
TORONTO, CHICAGO and MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced its financial...
Medexus Announces Expanded Availability of Gleolan® in Canada
February 25, 2021 09:00 ET
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO and MONTREAL, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it has...
Medexus Schedules Third Quarter Fiscal 2021 Conference Call
February 24, 2021 09:00 ET
|
Medexus Pharmaceuticals Inc
TORONTO and CHICAGO and MONTREAL, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it...
Medexus Announces Closing of $32.5 Million Public Offering, Including Exercise in Full of Over-Allotment Option
February 23, 2021 08:51 ET
|
Medexus Pharmaceuticals Inc
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, CHICAGO and MONTREAL, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc....
Medexus to Present at the Winter Wonderland Conference- Best Ideas from the Buy-Side
February 16, 2021 16:43 ET
|
Medexus Pharmaceuticals Inc
TORONTO, CHICAGO and MONTREAL, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it will...
Medexus Announces Upsize to Previously Announced Bought Deal Public Offering
February 03, 2021 10:10 ET
|
Medexus Pharmaceuticals Inc
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, CHICAGO and MONTREAL, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc....